SS
Shingo Suzuki

Highly Cited

96
Works
2,472
Citations
25
H-Index
Search Authors
Author Statistics
External Links
OpenAlex Profile ORCID Profile

Shingo Suzuki

Also known as: S Suzuki, S. Suzuki, SHINGO SUZUKI, Shingo SUZUKI, Shingo Suzuki

96

Total Works

2,472

Citations

25

H-Index

36

i10-Index

Citation & Works Trend by Year
38 years active
Top Research Topics
Cystic Fibrosis Research Advances (18) Renal Diseases and Glomerulopathies (12) CRISPR and Genetic Engineering (11) Chronic Kidney Disease and Diabetes (9) Virus-based gene therapy research (8)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 Targeted insertion of partial CFTR cDNA replicates native CFTR expression with restored channel function in CF airway epithelium Molecular Therapy — Nucleic Acids 0
2026 Elexacaftor-tezacaftor-ivacaftor for individuals with residual CFTR activity: an open-label, nonrandomized clinical trial Annals of the American Thoracic Society 0
2025 Generation of Region-specific Airway Basal Stem Cells from Human Pluripotent Stem Cells via Regulation of NOGGIN-BMP Axis bioRxiv (Cold Spring Harbor Laboratory) 2
2025 Evaluating elexacaftor/tezacaftor/ivacaftor (ETI; Trikafta™) for treatment of patients with non-cystic fibrosis bronchiectasis (NCFBE): A clinical study protocol PLoS ONE 6
2024 Evaluation of elexacaftor–tezacaftor–ivacaftor treatment in individuals with cystic fibrosis and CFTRN1303K in the USA: a prospective, multicentre, open-label, single-arm trial The Lancet Respiratory Medicine 34
2024 Evaluating elexacaftor/tezacaftor/ivacaftor (ETI; Trikafta™) for treatment of patients with non-cystic fibrosis bronchiectasis (NCFB): a clinical study protocol medRxiv 2
2024 Comparison of metronidazole versus clarithromycin in first‐line vonoprazan‐based triple therapy for Helicobacter pylori: A multicenter randomized trial in Japan JGH Open 1
2024 Elexacaftor-Tezacaftor-Ivacaftor Improves Clinical Outcomes in Individuals with CF Encoding N1303K CFTR SSRN Electronic Journal 3
2023 242 An open-label trial to evaluate elexacaftor-tezacaftor-ivacaftor and induced pluripotent stem cell–derived model systems in individuals with residual CFTR activity Journal of Cystic Fibrosis 0
2022 Ethanol concentration induces production of 3,4-dihydroxyphenylacetic acid and homovanillic acid in mouse brain through activation of monoamine oxidase pathway Neuroscience Letters 4
2022 Seamless Gene Correction in the Human Cystic Fibrosis Transmembrane Conductance Regulator Locus by Vector Replacement and Vector Insertion Events Frontiers in Genome Editing 5
2022 Targeted Gene Insertion for Functional CFTR Restoration in Airway Epithelium Frontiers in Genome Editing 6
2021 Differentiation of human pluripotent stem cells into functional airway basal stem cells STAR Protocols 25
2020 Derivation of Airway Basal Stem Cells from Human Pluripotent Stem Cells Cell stem cell 244
2020 Correction of Airway Stem Cells: Genome Editing Approaches for the Treatment of Cystic Fibrosis Human Gene Therapy 40

Data source: OpenAlex API